389 related articles for article (PubMed ID: 36426674)
1. Liposomal amphotericin B-the future.
Hoenigl M; Lewis R; van de Veerdonk FL; Verweij PE; Cornely OA
J Antimicrob Chemother; 2022 Nov; 77(Suppl_2):ii21-ii34. PubMed ID: 36426674
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology of rare mould infections: implications for therapy.
Malani AN; Kauffman CA
Drugs; 2007; 67(13):1803-12. PubMed ID: 17722951
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B-the present.
Maertens J; Pagano L; Azoulay E; Warris A
J Antimicrob Chemother; 2022 Nov; 77(Suppl_2):ii11-ii20. PubMed ID: 36426672
[TBL] [Abstract][Full Text] [Related]
6. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
7. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
8. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
9. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
10. New therapies for fungal pneumonia.
Maertens J; Meersseman W; Van Bleyenbergh P
Curr Opin Infect Dis; 2009 Apr; 22(2):183-90. PubMed ID: 19276884
[TBL] [Abstract][Full Text] [Related]
11. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao PL; Huang LM; Hsueh PR
J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study.
Puerta-Alcalde P; Monzó-Gallo P; Aguilar-Guisado M; Ramos JC; Laporte-Amargós J; Machado M; Martin-Davila P; Franch-Sarto M; Sánchez-Romero I; Badiola J; Gómez L; Ruiz-Camps I; Yáñez L; Vázquez L; Chumbita M; Marco F; Soriano A; González P; Fernández-Cruz A; Batlle M; Fortún J; Guinea J; Gudiol C; García J; Ruiz Pérez de Pipaón M; Alastruey-Izquierdo A; Garcia-Vidal C
J Infect; 2023 Jul; 87(1):46-53. PubMed ID: 37201859
[TBL] [Abstract][Full Text] [Related]
14. [Emerging azole antifungals].
Wolff M; Bouadma L; Mourvillier B
Therapie; 2006; 61(3):227-33. PubMed ID: 16989123
[TBL] [Abstract][Full Text] [Related]
15. [Invasive fungal infection over the last 30 years].
Silva JT; Ruiz-Camps I; Aguado JM
Rev Iberoam Micol; 2021; 38(2):47-51. PubMed ID: 34294520
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal infections: the challenge continues.
Gullo A
Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostics and therapy for invasive fungal infections in an intensive care unit].
Koch S; Haefner H; Huenger F; Haase G; Wildberger J; Lemmen SW
Anaesthesist; 2005 Oct; 54(10):1047-64; quiz 1065-6. PubMed ID: 16211405
[TBL] [Abstract][Full Text] [Related]
18. Approaches to fungal diagnosis in transplantation.
Patterson TF
Transpl Infect Dis; 1999 Dec; 1(4):262-72. PubMed ID: 11428997
[TBL] [Abstract][Full Text] [Related]
19. Changes in the epidemiological landscape of invasive mould infections and disease.
Lass-Flörl C; Cuenca-Estrella M
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
[TBL] [Abstract][Full Text] [Related]
20. Emerging moulds: epidemiological trends and antifungal resistance.
Miceli MH; Lee SA
Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
